{"entity":{"type":"insider","cik":"0001746372","url":"/insider/0001746372","json_url":"/insider/0001746372.json","name":"Miller Joseph M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":8,"first":"2019-06-11","last":"2025-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Miller Joseph M","source":"filing","n_filings":8,"first_seen":"2019-06-11","last_seen":"2025-03-04"}],"transactions":[{"id":4723584,"accession":"0001600620-25-000020","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001600620-25-000020","line_url":"/filing/0001600620-25-000020#line-4","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001746372","owner_name":"Miller Joseph M","owner_display_name":"Miller Joseph M","owner_url":"/insider/0001746372","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56154.0,"shares_display":"56,154","price_per_share":7.92,"price_display":"7.92","price_state":"stated","total_value":444739.68,"total_display":"444,739.68","total_whole":"444,740","shares_owned_after":577361.0,"shares_owned_after_display":"577,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-04","scope":"insider"},{"id":4723580,"accession":"0001600620-25-000020","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001600620-25-000020","line_url":"/filing/0001600620-25-000020#line-3","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001746372","owner_name":"Miller Joseph M","owner_display_name":"Miller Joseph M","owner_url":"/insider/0001746372","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61859.0,"shares_display":"61,859","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":494872.0,"total_display":"494,872.00","total_whole":"494,872","shares_owned_after":633515.0,"shares_owned_after_display":"633,515","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider"},{"id":2162697,"accession":"0001600620-24-000037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001600620-24-000037","line_url":"/filing/0001600620-24-000037#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001746372","owner_name":"Miller Joseph M","owner_display_name":"Miller Joseph M","owner_url":"/insider/0001746372","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34811.0,"shares_display":"34,811","price_per_share":5.6,"price_display":"5.60","price_state":"stated","total_value":194941.6,"total_display":"194,941.60","total_whole":"194,942","shares_owned_after":495928.0,"shares_owned_after_display":"495,928","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-06","filed_date":"2024-03-07","scope":"insider"},{"id":9292955,"accession":"0001600620-24-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001600620-24-000014","line_url":"/filing/0001600620-24-000014#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001746372","owner_name":"Miller Joseph M","owner_display_name":"Miller Joseph M","owner_url":"/insider/0001746372","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11398.0,"shares_display":"11,398","price_per_share":8.78,"price_display":"8.78","price_state":"stated","total_value":100074.44,"total_display":"100,074.44","total_whole":"100,074","shares_owned_after":331112.0,"shares_owned_after_display":"331,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2024-02-22","scope":"insider"},{"id":8088431,"accession":"0001628280-23-006531","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-23-006531","line_url":"/filing/0001628280-23-006531#line-2","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001746372","owner_name":"Miller Joseph M","owner_display_name":"Miller Joseph M","owner_url":"/insider/0001746372","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11296.0,"shares_display":"11,296","price_per_share":8.94,"price_display":"8.94","price_state":"stated","total_value":100986.24,"total_display":"100,986.24","total_whole":"100,986","shares_owned_after":331214.0,"shares_owned_after_display":"331,214","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-06","scope":"insider"},{"id":6435298,"accession":"0001628280-22-005127","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-22-005127","line_url":"/filing/0001628280-22-005127#line-2","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001746372","owner_name":"Miller Joseph M","owner_display_name":"Miller Joseph M","owner_url":"/insider/0001746372","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3060.0,"shares_display":"3,060","price_per_share":12.01,"price_display":"12.01","price_state":"stated","total_value":36750.6,"total_display":"36,750.60","total_whole":"36,751","shares_owned_after":6610.0,"shares_owned_after_display":"6,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-04","scope":"insider"},{"id":4392088,"accession":"0001628280-21-009835","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-009835","line_url":"/filing/0001628280-21-009835#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001746372","owner_name":"Miller Joseph M","owner_display_name":"Miller Joseph M","owner_url":"/insider/0001746372","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":9.74,"price_display":"9.74","price_state":"stated","total_value":9740.0,"total_display":"9,740.00","total_whole":"9,740","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-11","scope":"insider"},{"id":7958448,"accession":"0001578563-19-000039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001578563-19-000039","line_url":"/filing/0001578563-19-000039#line-1","is_derivative":false,"issuer_cik":"0001534120","issuer_name":"Cerecor Inc.","issuer_ticker":"CERC","issuer_name_source":null,"issuer_url":"/issuer/0001534120","owner_cik":"0001746372","owner_name":"Miller Joseph M","owner_display_name":"Miller Joseph M","owner_url":"/insider/0001746372","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2598.0,"shares_display":"2,598","price_per_share":2.8475,"price_display":"2.85","price_state":"stated","total_value":7397.805,"total_display":"7,397.80","total_whole":"7,398","shares_owned_after":48777.0,"shares_owned_after_display":"48,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-11","scope":"insider"},{"id":8105465,"accession":"0001578563-19-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001578563-19-000022","line_url":"/filing/0001578563-19-000022#line-1","is_derivative":false,"issuer_cik":"0001534120","issuer_name":"Cerecor Inc.","issuer_ticker":"CERC","issuer_name_source":null,"issuer_url":"/issuer/0001534120","owner_cik":"0001746372","owner_name":"Miller Joseph M","owner_display_name":"Miller Joseph M","owner_url":"/insider/0001746372","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1179.0,"shares_display":"1,179","price_per_share":2.8475,"price_display":"2.85","price_state":"stated","total_value":3357.2025,"total_display":"3,357.20","total_whole":"3,357","shares_owned_after":46179.0,"shares_owned_after_display":"46,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-10","filed_date":"2019-06-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001600620","name":"Aurinia Pharmaceuticals Inc.","url":"/issuer/0001600620","role":"Officer (Chief Financial Officer)","n_filings":6,"first_seen":"2021-05-11","last_seen":"2025-03-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001534120","name":"Cerecor Inc.","url":"/issuer/0001534120","role":"Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2019-06-11","last_seen":"2019-12-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001746372","retrieved_at":"2026-08-23T08:57:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}